Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD4+ regulatory cells as a potential immunotherapy.

Zoltán Fehérvari1, Shimon Sakaguchi

  • 1Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Japan. zed72@frontier@-kyoto-u.ac.jp

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|September 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foxp3 drives context-dependent epigenetic programs that define regulatory T cell molecular identity and function.

Science immunology·2026
Same author

PD-1 antibody-bound progenitor-exhausted CD8<sup>+</sup> T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer.

Nature communications·2026
Same author

Stable and functional regulatory T cell attenuates fibrotic remodeling in heart failure.

Regenerative therapy·2026
Same author

T Cell Receptor Signaling and Immune Tolerance: From Autoimmunity to Cancer Immunity.

Annual review of immunology·2026
Same author

ROSE12, a novel anti-CTLA-4 FcγRs binding-enhanced antibody activated by extracellular adenosine triphosphate, shows tumor-selective regulatory T-cell depletion and antitumor efficacy without systemic immune activation.

Journal for immunotherapy of cancer·2026
Same author

Prostaglandin E<sub>2</sub>-EP2/EP4 signaling induces the tumor-infiltrating Treg phenotype for tumor growth.

Proceedings of the National Academy of Sciences of the United States of America·2025

Regulatory T (T(R)) cells are crucial for immune tolerance and have potential in treating various conditions. Harnessing their suppressive abilities offers a promising avenue for cell-based immunotherapy.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • CD4(+) regulatory T (T(R)) cells are essential for maintaining self-tolerance.
  • Their role extends to transplantation, tumor immunity, allergy, and microbial immunity.

Purpose of the Study:

  • To explore harnessing the suppressive capabilities of T(R) cells.
  • To develop potent cell-based immunotherapy for clinical applications.

Main Methods:

  • Focus on the suppressive functions of naturally occurring and ex vivo generated T(R) cells.

Main Results:

  • Experimental data confirm the key role of T(R) cells in self-tolerance.
  • T(R) cells are increasingly recognized for their importance in diverse clinical areas.

Related Experiment Videos

Conclusions:

  • Harnessing T(R) cell suppressive abilities provides access to potent cell-based immunotherapy.
  • This approach holds significant promise for clinical applications in immune-related diseases and conditions.